In the 21st century, research on stem cells for the treatment of chronic diseases is the most popular approach among medical scientists. In 2012, the Nobel Prize in Physiology and Medicine was awarded to scientists who studied stem cells. As it is a popular field of study, there are many researchers working on stem cells which involve different research model and direction.
HES CELL has accumulated extensive experience for the use of embryonic stem cells combined with mesenchymal stem cells in the clinical application since 2000.
The mesenchymal stem cells used by HES CELL are originated from the human umbilical cord tissue or also known as Wharton’s Jelly (extracted from the subamnion, the intermediate and the perivascular Wharton's Jelly of umbilical cord). These zones of the umbilical cord possess the most abundant and ideal source of mesenchymal stem cells.
Extensive studies on mesenchymal stem cells by medical scientists over years have confirmed that the mesenchymal stem cells are effective for the indications as below:
- Anti-aging (skin repair)
- Cardiovascular diseases and its complications
- Repair nervous system
- Repair and regeneration of skeletal system
- Liver diseases
- Autoimmune diseases
- Premature ovarian failure or sexual dysfunction
In recent years, the application of mesenchymal stem cells has been widely conducted because the source of stem cells is easily accessible and there is no ethical issue. HES CELL will continue to work hard in exploring a variety of stem cell therapies.
